Handling Missing Data in Clinical Trials: An Overview

被引:0
|
作者
William R. Myers
机构
[1] Procter and Gamble Pharmaceuticals,Department of Biometrics and Statistical Sciences
[2] Procter and Gamble Pharmaceuticals,Department of Biometrics and Statistical Sciences
来源
Drug information journal : DIJ / Drug Information Association | 2000年 / 34卷 / 2期
关键词
Clinical trials; Missing data; Dropouts; Imputation methods; Missing-data mechanism;
D O I
暂无
中图分类号
学科分类号
摘要
A major problem in the analysis of clinical trials is missing data caused by patients dropping out of the study before completion. This problem can result in biased treatment comparisons and also impact the overall statistical power of the study. This paper discusses some basic issues about missing data as well as potential “watch outs.” The topic of missing data is often not a major concern until it is time for data collection and data analysis. This paper provides potential design considerations that should be considered in order to mitigate patients from dropping out of a clinical study. In addition, the concept of the missing-data mechanism is discussed. Five general strategies of handling missing data are presented: I. Complete-case analysis, 2. “Weighting methods,” 3. Imputation methods, 4. Analyzing data as incomplete, and 5. “Other” methods. Within each strategy, several methods are presented along with advantages and disadvantages. Also briefly discussed is how the International Conference on Harmonization (ICH) addresses the issue of missing data. Finally, several of the methods that are illustrated in the paper are compared using a simulated data set.
引用
收藏
页码:525 / 533
页数:8
相关论文
共 50 条
  • [21] Missing data in clinical trials for weight management
    McEvoy, Bradley W.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2016, 26 (01) : 30 - 36
  • [22] Missing repeated measures data in clinical trials
    Pugh, Stephanie L.
    Brown, Paul D.
    Enserro, Danielle
    NEURO-ONCOLOGY PRACTICE, 2022, 9 (01) : 35 - 42
  • [23] Methods for handling missing binary data in substance use disorder trials
    Ren, Boyu
    Lipsitz, Stuart R.
    Weiss, Roger D.
    Fitzmaurice, Garrett M.
    DRUG AND ALCOHOL DEPENDENCE, 2023, 250
  • [24] Handling missing values in cost effectiveness analyses that use data from cluster randomized trials
    Diaz-Ordaz, K.
    Kenward, Michael G.
    Grieve, Richard
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2014, 177 (02) : 457 - 474
  • [25] MISSING INACTION: PREVENTING MISSING OUTCOME DATA IN RANDOMIZED CLINICAL TRIALS
    Wittes, Janet
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (06) : 957 - 968
  • [26] The Adjustment Methods for Missing Data in Clinical Trials of Traditional Chinese Medicine
    Xie, Yang
    Wang, Jia-jia
    INTERNATIONAL CONFERENCE ON MECHANICAL, ELECTRONIC AND INFORMATION TECHNOLOGY (ICMEIT 2018), 2018, : 562 - 564
  • [27] Statistical analysis and handling of missing data in cluster randomized trials: a systematic review
    Mallorie H. Fiero
    Shuang Huang
    Eyal Oren
    Melanie L. Bell
    Trials, 17
  • [28] A general method for handling missing binary outcome data in randomized controlled trials
    Jackson, Dan
    White, Ian R.
    Mason, Dan
    Sutton, Stephen
    ADDICTION, 2014, 109 (12) : 1986 - 1993
  • [29] Missing Data in Alcohol Clinical Trials with Binary Outcomes
    Hallgren, Kevin A.
    Witkiewitz, Katie
    Kranzler, Henry R.
    Falk, Daniel E.
    Litten, Raye Z.
    O'Malley, Stephanie S.
    Anton, Raymond F.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 (07) : 1548 - 1557
  • [30] Statistical analysis and handling of missing data in cluster randomized trials: a systematic review
    Fiero, Mallorie H.
    Huang, Shuang
    Oren, Eyal
    Bell, Melanie L.
    TRIALS, 2016, 17